Cystic fibrosis mutations and genotype-pulmonary phenotype analysis

被引:22
作者
Braun, Andrew T.
Farrell, Philip M.
Ferec, Claude
Audrezet, Marie Pierre
Laxova, Anita
Li, Zhanhai
Kosorok, Michael R.
Rosenberg, Marjorie A.
Gershan, William M.
机构
[1] Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53705 USA
[2] Univ Wisconsin, Dept Biostat Med Informat, Madison, WI 53705 USA
[3] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA
[4] Univ Bretagne Occidentale, Genet Mol Lab, Brest, France
基金
美国国家卫生研究院;
关键词
cystic fibrosis; genotype; phenotype; lung disease;
D O I
10.1016/j.jcf.2005.09.008
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Although there are more than 1000 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, most of them are uncommon and only limited information exists regarding genotype-pulmonary phenotype relationships. Methods: We determined and classified the CFTR mutations using denaturing high-performance liquid chromatography and developed new, quantitative methods to categorize pulmonary phenotypes. Results: Two novel alleles were discovered, namely G1047R and 1525-2A-->G, which were accompanied by F508del and G551D mutations, respectively. Assessment of numerous options revealed that CF pulmonary phenotype categorization in children cannot be accomplished with clinical or pulmonary function data but is facilitated by longitudinal quantitative chest radiology. It was most useful to categorize pulmonary disease status by evaluating the typical pattern of abnormalities in patients homozygous for the F508del mutation, and then compare patients with minor mutations to this typical CF pulmonary phenotype. By this method, both patients with novel mutations have pulmonary phenotypes typical of F508del homozygotes. However, patients with class TV mutations (e.g., R347P) or with pancreatic sufficiency showed serial chest radiographs that were atypically mild. Conclusions: Longitudinal quantitative chest radiography provides a new strategy for CF pulmonary phenotype categorization that should be useful for genotype-phenotype delineation in individual patients and in both epidemiologic studies and clinical trials involving groups of children with CF. (C) 2005 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 39 条
  • [1] Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening
    Bobadilla, JL
    Macek, M
    Fine, JP
    Farrell, PM
    [J]. HUMAN MUTATION, 2002, 19 (06) : 575 - 606
  • [2] Bobadilla Joseph L, 2002, Adv Pediatr, V49, P131
  • [3] BRASFIELD D, 1979, PEDIATRICS, V63, P24
  • [4] Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
    Corey, M
    Edwards, L
    Levison, H
    Knowles, M
    [J]. JOURNAL OF PEDIATRICS, 1997, 131 (06) : 809 - 814
  • [5] *CYST FIBR GEN PHE, 1993, NEW ENGL J MED, V3, P1308
  • [6] Nomenclature for the description of human sequence variations
    den Dunnen, JT
    Antonarakis, E
    [J]. HUMAN GENETICS, 2001, 109 (01) : 121 - 124
  • [7] Cystic fibrosis: gene therapy or preventive gene transfer?
    Drittanti, L
    Masciovecchio, MV
    Gabbarini, J
    Vega, M
    [J]. GENE THERAPY, 1997, 4 (10) : 1001 - 1003
  • [8] Dugueperoux Ingrid, 2004, J Cyst Fibros, V3, P259, DOI 10.1016/j.jcf.2004.07.004
  • [9] Farrell P M, 2000, Adv Pediatr, V47, P79
  • [10] Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis
    Farrell, PM
    Li, ZH
    Kosorok, MR
    Laxova, A
    Green, CG
    Collins, J
    Lai, HC
    Rock, MJ
    Splaingard, ML
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 168 (09) : 1100 - 1108